chrisvoncsefalvay/vaers-outcomes huggingface dataset:
sore arm; felt so bad; fever; achiness; felt tired that lasted all day; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), FEELING ABNORMAL (felt so bad), PYREXIA (fever), MYALGIA (achiness) and FATIGUE (felt tired that lasted all day) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In March 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In March 2021, the patient experienced PAIN IN EXTREMITY (sore arm), FEELING ABNORMAL (felt so bad), PYREXIA (fever), MYALGIA (achiness) and FATIGUE (felt tired that lasted all day). At the time of the report, PAIN IN EXTREMITY (sore arm), FEELING ABNORMAL (felt so bad), PYREXIA (fever), MYALGIA (achiness) and FATIGUE (felt tired that lasted all day) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment information included Tylenol. concomitant medications are not provided.
Rash developed around the left arm inoculation site. Blotchy sections, papules. Itchy.
Introduction: Chronic sinusitis causes significant morbidity. Atopy and immunodeficiency are known predisposing risk factors to chronic sinusitis. Recently, multiple studies have shown a linkage between patients with chronic sinusitis who do not meet diagnostic criteria with cystic fibrosis (CF) and a single cystic fibrosis gene mutation. The CF gene was discovered years ago, its role in CF syndrome is still unclear. In these patients, intravenous immunoglobulin (IVIg) has been used for immune replacement and immunomodulation. We describe our experience using IVIg in 2 patients with full CF mutation and 6 patients with a single mutation. Clinical Data: Our 8 patients ranged in age from 3 to 56 years with various CF mutations. The gene mutations included F508CF in 2 patients; single copy of F505CF in 4 patients; W1282X in 1 patient; and R117H in 1 patient. All patients were diagnosed with chronic sinus disease and had received repeated courses of antibiotic therapy. All had positive CT scans for the sinuses. An immune work-up was performed: all patients had low borderline lgG levels (450 plus or minus 56); 4 patients had an lgG3 subclass deficiency; 2 patients had low lgA; and 1 patient had low lgM. All patients had low isohemagglutinin levels. All patients had no response to pneumococcal vaccine (manufacturer unknown), and 4 had a low response to tetanus, polio and Haemophilus influenzae type B vaccines. Results: All patients were treated with IVIg (600-800 mg/Kg body weight) and recorded major improvement in the incidence of acute sinusitis with no further sinus surgeries recorded. A decreased use of antibiotic therapy was noted. Patients and caregivers reported that quality of life of energy levels had increased an average of 4 steps on a scale of 1-10. The full CF mutation patients were able to preserve their lung function and no hospitalizations were recorded after therapy was instituted. Discussion: The CF mutation combined with an aberrant immune system can lead to chronic sinus infections in single mutations, as well as lung destruction in full CF mutation, from various infectious and inflammatory pathways. IVIg therapy can benefit these patients by reducing the number of infections. IVIg can benefit patients with CF mutation: - In single mutation as immune replacement in preventing chronic sinus infection. - In full CF mutation as an immunomodulatory agent and to reduce post-infectious inflammatory changes. Additional information has been requested.
headaches and muscle aches and pain in my joints bell palsy symptoms fatigue nausea throat inflamation
Pt came for doctor's office visit for routine well care check on 2/8/19. 4 yo vaccines administered per routine. KINRIX, MMRV and flu administered. Pt tolerated well post vaccination. KINRIX administered in Right deltoid, MMRV administered LUOA, Flu vaccine administered Left deltoid. Pt complained of Right arm redness, swelling 2/10/19 and was taken to ED on 2/11/19 by mother. During ED visit pt dx with cellulitis and BACTRIM prescribed. Pt seen for f/u by PCP on 2/15/19 with resolution of cellulitis but still completing 2-3 days more of BACTRIM.
Patient stated on 3 days post-dose on June 14, 2021, she began to feel lethargic. On June 15, 2021 patient started running low grade fever and treated with ibuprofen as needed. On Saturday, June 19, 2021 through Monday, June 21, 2021 pt was experiencing sharp chest pains with laying down and with movement as well as difficulty deep breathing. Patient continued to take ibuprofen to relieve symptoms. All symptoms resolved by Monday, June 21, 2021.
Initially nausea, migraine, hives at injection point, redness and swelling. After one day, the nausea went away. The migraine lingered for 4 days. The hives and itching lasted one week.
Telephone call- c/o rash on stomach + trunk area also unilateral ankle swollen (L ankle).
Three days after moderna vaccine, I had Afib starting when I was sleeping and lasting thee hours.  My pulse was 169.  I woke up with racing heartbeat and unusually urine output.
Patient experience fever, weakness, congestion, cough, fatigue, and soreness to L arm. Started 16 hours after vaccinated, and continue to 48 hours, with worsening fatigue, and weakness.
Fainted approximately 2 minutes after injection. Woke up approximately 1 minute later and immediately vomited.
I got a whelp below the injection site then it travels to below my elbow the next day,  it hurt so bad I can't hardly use it. Every time I use it it hurt so  bad. It's been 2 weeks since the vaccine.
Pt received TDAP, MENACTRA, HPV vaccines today. About 10 seconds later, she started to shake, eyes rolled into her head, her vision went black, and she collapsed onto the examining table. She was quickly positioned on her back with legs elevated. She turned pale. O2 = 100%. She was responsive. Patient was observed for 15 min. and recovered fully. Upon discharge her O2 = 100%; HR 88; BP 112/68. She has no h/o syncopal episodes with imms.
Ear ache; Fever of 102+; Headache; Chills; This is a spontaneous report from a contactable Consumer (Patient). A 26-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot# unknown), via an unspecified route of administration on 06Feb2021 at 11:45 (at the age of 26-years) as single dose for Covid-19 immunization. The patient medical history and concomitant medications were not reported. Patient had COVID prior vaccination on an unspecified date. Patient received no other vaccine in four weeks. On 07Feb2021 at 01:00 (one day after vaccination), patient experienced fever of 102+, headache, ear ache, chills. No therapeutic measures were given for any of events. Patient underwent lab test: body temperature: fever of 102+ on 07Feb2021. Patient had no COVID tested done post vaccination. The outcome of all the events was not recovered.  Information about Lot/ Batch number requested.
This case was reported in a literature article and described the occurrence of uveitis in a 26-year-old female subject who was vaccinated with hepatitis B vaccine recombinant (Hepatitis B vaccine, manufacturer unspecified). On an unspecified date the subject received 2nd dose of Hepatitis B vaccine (unknown). One day after vaccination with Hepatitis B vaccine, the subject experienced uveitis, dizziness and nausea. This case was assessed as medically serious by GSK. This is one of the 32 reported cases (B0662264A till B0662297A) of uveitis which occurred after hepatitis b vaccine between 1982 and 2009. It appeared that all subject's recovered, although the treatment for uveitis was not reported. The uveitis occurred in average of 3 days after vaccination in patients without other risk factors or disease that could cause uveitis. This could be consistent with immune complex deposition or nonspecific activation from vaccine adjuvants. Although there was a debate that uveitis occurs because of hepatitis B infection there was evidence that immune complex deposition diseases such as glomerulonephritis and cryoglobulinemia occurred during chronic hepatitis B infection. Furthermore it was possible the surface antigen of the vaccine and the hepatitis B antibodies of the immune response after vaccination formed immune complexes, which initiated the ocular response of uveitis.
Site: Itching at Injection Site-Medium, Site: Pain at Injection Site-Medium, Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Systemic: Chills-Mild, Systemic: Fever-Mild, Additional Details: Patient's injection site size of a baseball and is red, and really warm
Anaphylaxis within 5 minutes of vaccine. Itchy at local site. Within 15 minutes developed diffuse rash, sneezing. Sent to Emergency Room received epinephrine, BENADRYL, SINGULAIR, IVF.
Intermittent dizziness and it doesn't last very long usually its usually couple of times a day; This is a spontaneous report from a contactable nurse, the patient. A 31-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Lot "EJ then it's either I or 1, I don't know then 685", Expiry Date: 31Mar2021) solution for injection intramuscular on 19Dec2020 (at the age of 31-years-old) as a single dose for COVID-19 vaccination. Pregnancy status was not reported. Medical history was unknown. Concomitant medication included multivitamins. The patient stated, "I just wanted to know if it's normal or not, I got this first half of the Covid Vaccine on the 19Dec2020 and ever since I have been having like intermittent dizziness (19Dec2020) and it doesn't last very long usually its usually couple of times a day but I just wanted to know if that's normal and if it is how long before it stops?" No treatment was provided for the event intermittent dizziness. The outcome of the event intermittent dizziness was unknown.  The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
a flood of heat throughout my body; pain in my calf muscle; tingling; Woke me up all night; super dizzy; This is a spontaneous report from a contactable consumer (patient). A 40-year-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EL3302), via an unspecified route of administration in the left arm on 12Jan2021 10:00 at a single dose for COVID-19 immunization. There were no medical history. The patient is not pregnant. Concomitant medication included amoxicillin. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination and had not been tested for COVID-19 since the vaccination. The patient experienced super dizzy on 12Jan2021 10:06, a flood of heat throughout her body, pain in her calf muscle, tingling, and it woke her up all night on 12Jan2021 12:00. Outcome of the events was recovering.
Deep vein thrombosis (DVT). Woke up on 4th day after vaccine (May 5, 2021) with pain in calf. Swelling continued to get worse. Went to an emergency room just over one week after vaccine (May 8, 2021) and was diagnosed with DVT in the lower left calf (after D Dimer test and ultrasound). No family history of clotting issues. And no personal history of clotting issues. Currently on Rivaroxaban (Xarelto), 15 mg twice per day. Will be on for at least 3 months (moving to 20 mg once per day after the first 21 days).
Vaccine kept in refrigerator on 10/29/2021, expiration date is 10/13/2021, administered on 11/03/2021; 606 doses were given after expiration date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date) and PRODUCT STORAGE ERROR (Vaccine kept in refrigerator on 10/29/2021, expiration date is 10/13/2021, administered on 11/03/2021) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine kept in refrigerator on 10/29/2021, expiration date is 10/13/2021, administered on 11/03/2021). At the time of the report, EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date) and PRODUCT STORAGE ERROR (Vaccine kept in refrigerator on 10/29/2021, expiration date is 10/13/2021, administered on 11/03/2021) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication of the patient was not reported.  Date the vial was placed in the refrigerator was 29-OCT-2021. There was no temperature excursion. The reporter reported that there was a confusion between the expiration date printed in the carton and the expiration date when the QR code was scanned.  The patient did not experience any adverse event.  No treatment information was provided by the reporter.
Patient received PREVNAR13 and 24 hours post vaccination, patients arm had a knot and was warm at the injection site.
The patient has knots in both legs at injection site. Use cool Compresses a Tylenol for the pain and fever.
Sore Arm; upset Stomach; Headache; Chills; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore Arm), ABDOMINAL DISCOMFORT (upset Stomach), HEADACHE (Headache) and CHILLS (Chills) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced PAIN IN EXTREMITY (Sore Arm), ABDOMINAL DISCOMFORT (upset Stomach), HEADACHE (Headache) and CHILLS (Chills). At the time of the report, PAIN IN EXTREMITY (Sore Arm), ABDOMINAL DISCOMFORT (upset Stomach), HEADACHE (Headache) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. Treatment information was not provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-060959 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-  MOD-2021-060959:1st dose case
NAUSEATED, FEVER, ACHEY, DIZZY, SWOLLEN GLAND UNDER ARM, TIRED NO ENERGY
Woke during the night (approx 11hrs post-vaccine) with 10/10 joint pain in shoulders and hips, unable to get comfortable; continued with pain, extreme weakness, exhaustion, nausea, and mild headache until approx 5pm the day after vaccine (Day 2).  Slept most of the day and through the following night.  Fainted x1 first thing in the morning; Vomited x1 after small snack and tea; unable to eat all day.  Symptoms resolved by day 3 and able to go to work
Erythema induration 5-6 cm surrounding injection site. Fever 102.
thigh had erythema and swelling from groin to knee, complete circumference of this (L) leg
1. STRONG HEADACHE 2. HIGH BLOOD PRESSURE: 160/68 ( I NEVER HAD HIGH BLOOD PRESSURE UNTIL THE DAY AFTER THE COVID VACCINE) 3. BLOOD IN MY LEFT EYE 4. CONSTANT HEADACHE AFTER THE DAY OF THE COVID VACCINE 5. CONSTANT HIGH BLOOD PRESSURE ONE DAY TO ANOTHER SINCE THE COVID VACCINE WITHOUT NEVER HAVING BEFORE ANY EVENT OF HIGH BLOOD PRESSURE 6. SYSTOLIC BLOOD PRESSURE HIGH BUT DIASTOLIC STAY NORMAL LOW. HEART RATE ALSO STAY NORMAL LOW. BUT SYSTOLIC BLOOD PRESSURE DIDN'T WENT AWAY NEITHER AFTER SEVERAL DAYS
It began Monday 12DEC2023 I had a bit of a cough I went for jury duty wearing a mask and I felt tired most of the day I took a COVID-19 test which was negative the next morning still not feeling well and tired I went to the church service early morning I went to my volunteer spot still coughing at one PM. I went to take a class but was tired and unwell went home took another test and it was positive. I had a fever of one hundred one to one hundred and two, aches but nothing real bad. I took a rapid test every other day after five days came out wearing a mask after about ten days I was negative on my tests. Interestingly my smart watch, my whole reading overnight was around zero point six degrees and oxygen level dropped by about six percent one night and my oximeter read about the same.
DID NOT TAKE LAST DOSE AS PRESCRIBED; This spontaneous case was received from a consumer on 24-May-2019. It describes a consumer who "did not take last dose as prescribed", while being on oral Vivotif capsule for a trip.  Case report: The consumer did not take the last dose as prescribed. The doses were taken on 04-May-2019, 06-May-2019, 08-May-2019, and 15-May-2019 respectively.  Action taken with Vivotif was not applicable.  The clinical outcome of the event was unknown.  Company's Comment: The causality of the event "did not take last dose as prescribed" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "did not take last dose as prescribed" was considered as not applicable.
doses administered after excursion; No adverse event; Prior to knowing that the vaccines which underwent a temperature excursion in the freezer were viable and patient received doses of the vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Prior to knowing that the vaccines which underwent a temperature excursion in the freezer were viable and patient received doses of the vaccine), PRODUCT TEMPERATURE EXCURSION ISSUE (doses administered after excursion) and NO ADVERSE EVENT (No adverse event) in a 63-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7147B) for COVID-19 prophylaxis.     No Medical History information was reported.   On 14-Oct-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 14-Oct-2022, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Prior to knowing that the vaccines which underwent a temperature excursion in the freezer were viable and patient received doses of the vaccine). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (doses administered after excursion) and NO ADVERSE EVENT (No adverse event). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Prior to knowing that the vaccines which underwent a temperature excursion in the freezer were viable and patient received doses of the vaccine), PRODUCT TEMPERATURE EXCURSION ISSUE (doses administered after excursion) and NO ADVERSE EVENT (No adverse event) outcome was unknown.     For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for POOR QUALITY PRODUCT ADMINISTERED (Prior to knowing that the vaccines which underwent a temperature excursion in the freezer were viable and patient received doses of the vaccine) and PRODUCT TEMPERATURE EXCURSION ISSUE (doses administered after excursion).    No concomitant medications were reported.  Reportedly, Pharmacist called to discuss a temperature excursion that occurred several days ago in the freezer. the excursion was found out in an audit and all the vaccines were viable. No adverse reactions reported for the patient.  No treatment medications were reported.
Pain in all joints.  Hands.  Back injuries flaring up.  Spinal pain. Groin pain.
Complaints of fever, never took temp but felt hot with generalized malaise, aches in legs for 3-4 days and then tremors to legs. Lasted approximately 7 weeks. Seen by private physician and was taken off current meds - Wellbutrin, Claritin, Nasarel at about day 4. Placed on steroids at that time. Was told by his physician that it was due to the egg protein in the vaccine. (OMIC). Serum Sickness No new terms added from Medical Record rec'd 12/12/2005.
Woke up 3:15 a.m., had vomiting and diarrhea, chills, severe muscle ache, and headache.  Vomiting lasted until 5:30 a.m.  Spent the rest of the day relaxing and worn out.  Was only able to eat soup 2X, and had 1 cup of tea.  Next day better, but tired.
Left arm sore; feeling light headed; In bed most of today; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Left arm sore), DIZZINESS (feeling light headed) and FATIGUE (In bed most of today) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 18-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-May-2021, the patient experienced PAIN IN EXTREMITY (Left arm sore), DIZZINESS (feeling light headed) and FATIGUE (In bed most of today). At the time of the report, PAIN IN EXTREMITY (Left arm sore), DIZZINESS (feeling light headed) and FATIGUE (In bed most of today) outcome was unknown.            For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.  Concomitant product use was not provided by the reporter.  Treatment medication use was not provided by the reporter.
Pt comes to clinic 9 days post Td. She felt some itching of the R upper arm 2 days previously, this AM (1/17/03) pt noted red swollen area the size if a grapefruit, Exam of R upper arm revealed erythema 4 inches X 4 inches there is a spot which has very fine scaling at the bottom of the lesion where the shot was given it is non tender non indurated. RX chlorpheniramine maleate 2 mgm 3 X day.